"Clinical Research Organization"

During the past decade, VIP Trials conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "VIP Trials" are "COVID-19" (1 trials), "Crohn's Disease" (1 trials), "Episodic Migraine" (1 trials), "Migraine" (1 trials) and "Moderate to Severe Ulcerative Colitis" (1 trials). Many other conditions were trialed in "VIP Trials" in a lesser frequency.

Most popular intervention types in "VIP Trials" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "0 mg Induction ONLY" (1 trials), "150 mg Induction/Chronic" (1 trials), "450 mg Induction/Chronic" (1 trials) and "50 mg Induction/Chronic" (1 trials). Other intervention names were less common.

The vast majority of trials in "VIP Trials" are 5 trials for "All" genders.

Currently, there are NaN active trials in "VIP Trials". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in VIP Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VIP Trials, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".